Results 11 to 20 of about 16,904 (296)

Tezepelumab treatment for allergic bronchopulmonary aspergillosis

Respirology Case Reports, 2023
An 82‐year‐old man had been diagnosed with asthma. He experienced repeated exacerbations requiring treatment with a systemic corticosteroid despite being treated with medications including high‐dose fluticasone furoate/umeclidinium/vilanterol ...
Hiroaki Ogata, Kachi Sha, Yasuaki Kotetsu, Aimi Enokizu‐Ogawa, Katsuyuki Katahira, Akiko Ishimatsu, Kazuhito Taguchi, Atsushi Moriwaki, Makoto Yoshida   +8 more
doaj   +2 more sources

Aspergillus Sensitization and Allergic Bronchopulmonary Aspergillosis in Asthmatic Children: A Systematic Review and Meta-Analysis [PDF]

Diagnostics, 2023
Background: The prevalence of aspergillus sensitization (AS) and allergic bronchopulmonary aspergillosis (ABPA) in asthmatic children remains unclear.
Ritesh Agarwal, Valliappan Muthu, Inderpaul Singh Sehgal, Sahajal Dhooria, Kuruswamy Thurai Prasad, Soundappan Kathirvel, Shivaprakash M. Rudramurthy, Ashutosh N. Aggarwal, Arunaloke Chakrabarti   +8 more
openalex   +2 more sources

Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial [PDF]

European Respiratory Journal, 2021
Background In allergic bronchopulmonary aspergillosis (ABPA), prolonged nebulised antifungal treatment may be a strategy for maintaining remission. Methods We performed a randomised, single-blind, clinical trial in 30 centres.
Cendrine Godet, Françis Couturaud, S. Marchand‐Adam, Christophe Pison, Frédéric Gagnadoux, Élodie Blanchard, Camille Taillé, Bruno Philippe, Sandrine Hirschi, Claire Andréjak, Arnaud Bourdin, Cécile Chenivesse, S. Dominique, Laurence Bassinet, M. Murris‐Espin, F. Rivière, Gilles Garcia, D. Caillaud, F.–X. Blanc, François Goupil, Anne Bergeron, Anne Gondouin, Jean‐Pierre Frat, Thomas Flament, B. Camara, Pascaline Priou, Anne‐Laure Brun, François Laurent, Stéphanie Ragot, J. Cadranel, Cendrine Godet, Françis Couturaud, J. Cadranel, J.-P. Frat, A-L. Brun, François Laurent, S. Marchand‐Adam, Christophe Pison, Frédéric Gagnadoux, Élodie Blanchard, Camille Taillé, Philippe Bouvet, Sandrine Hirschi, Claire Andréjak, Cécile Chenivesse, S. Dominique, L. Bassinet, M. Murris‐Espin, F. Rivière, Gilles Garcia, D. Caillaud, F.–X. Blanc, François Goupil, Anne Gondouin, Thomas Flament, B. Camara, Pascaline Priou, Stéphanie Ragot, S. Ragot   +58 more
openalex   +2 more sources

New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis/mycosis and its validation

Journal of Allergy and Clinical Immunology, 2020
Koichiro Asano, Akira Hebisawa, Takashi Ishiguro, Noboru Takayanagi, Yasuhiko Nakamura, Junko Suzuki, Naoki Okada, Jun Tanaka, Yuma Fukutomi, Shigeharu Ueki, Koichi Fukunaga, Satoshi Konno, Hiroto Matsuse, Katsuhiko Kamei, Masami Taniguchi, Terufumi Shimoda, Tsuyoshi Oguma   +16 more
openalex   +2 more sources

Allergic Bronchopulmonary Aspergillosis [PDF]

Allergy & Clinical Immunology International - Journal of the World Allergy Organization, 2005
Allergic bronchopulmonary aspergillosis (ABPA) is an immunologically mediated lung disease which occurs predominantly in patients with asthma, and is caused by hypersensitivity to colonized Aspergillus fumigatus. It is a chronic, relapsing disorder which can clinically range from mild asthma to fibrotic lung disease.
I, Tillie-Leblond, A-B, Tonnel
  +7 more sources

Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma-Factor analysis.

Allergy. European Journal of Allergy and Clinical Immunology, 2023
BACKGROUND Allergic bronchopulmonary aspergillosis (ABPA) develops in the presence or absence of asthma, either atopic or nonatopic. We have tried to explore the essential components in the pathogenesis of the disease, which are either consistent and ...
N. Okada, Yoshiro Yamamoto, T. Oguma, Jun Tanaka, K. Tomomatsu, Y. Shiraishi, H. Matsuse, T. Shimoda, H. Kimura, K. Watai, Toshiyuki Harada, Y. Fujita, Y. Obase, M. Suzukawa, J. Suzuki, N. Takayanagi, T. Ishiguro, K. Masaki, K. Fukunaga, K. Asano   +19 more
semanticscholar   +1 more source

Fungal-Driven Airways Dis-Immunity From Asthma to Allergic Bronchopulmonary Aspergillosis: Dissecting Similarities and Differences. An EAACI Task Force Report. [PDF]

Allergy
ABSTRACT Severe asthma and allergic bronchopulmonary aspergillosis (ABPA) do not rarely coexist and share several similarities in terms of pathobiological background, together with overlapping clinical manifestations, misleading the correct diagnosis. Within that scenario, severe asthma with fungal sensitization (SAFS) further complicates the correct ...
Caminati M, Annesi-Maesano I, Feleszko W, Guida G, Janson C, Hägg S, Malinovschi A, Tanno L, Vitte J, Ambrosani F, Maule M.   +10 more
europepmc   +2 more sources

Clinical Characteristics of Difficult-To-Treat Allergic Bronchopulmonary Aspergillosis and Its Prediction Score. [PDF]

Allergy
A retrospective cohort of newly diagnosed treatment‐naive patients with ABPA in Japan who were followed up for up to 3 years after the primary diagnosis was analyzed to explore the clinical remission rate and clinical characteristics of ABPA resistant to standard treatment or prone to exacerbation during/after treatment.
Tanaka J, Oguma T, Ishiguro T, Taniguchi H, Nishiuma T, Tateno H, Matsumoto H, Koshimizu N, Ito Y, Matsunaga K, Matsushima H, Uchida Y, Yokomura K, Yasuba H, Suzuki J, Hattori S, Okada N, Tomomatsu K, Asano K, ABPM Research Program.   +19 more
europepmc   +2 more sources

Evaluation of Simpler Criteria for Diagnosing Allergic Bronchopulmonary Aspergillosis Complicating Asthma

Frontiers in Cellular and Infection Microbiology, 2022
Background The modified International Society for Human and Animal Mycology (ISHAM) allergic bronchopulmonary aspergillosis (ABPA) working group (AWG) criteria lists up to five components for diagnosing ABPA in asthmatics.
R. Agarwal, P. Saxena, V. Muthu, I. Sehgal, S. Dhooria, K. Prasad, A. Aggarwal, A. Chakrabarti   +7 more
semanticscholar   +1 more source

An Interesting Case of Allergic Bronchopulmonary Aspergillosis Resulting in Type II Respiratory Failure

Journal of Respiration, 2022
Aspergillus fumigatus can cause an immunological hypersensitivity reaction known as allergic bronchopulmonary aspergillosis (ABPA), which often worsens asthma and cystic fibrosis patients’ conditions.
Aman Nagar, Shubhajeet Roy, Jyoti Bajpai, Ajay Kumar Verma, Surya Kant   +4 more
doaj   +1 more source